scispace - formally typeset
H

Huan Liu

Researcher at Wuhan University

Publications -  10
Citations -  985

Huan Liu is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 4, co-authored 7 publications receiving 718 citations. Previous affiliations of Huan Liu include GE Healthcare.

Papers
More filters
Journal ArticleDOI

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.

TL;DR: Postmortem examinations of lung, liver, and heart in four patients who died of COVID-19 pneumonia show advanced diffuse alveolar damage, as well as superimposed bacterial pneumonia in some patients.
Journal ArticleDOI

Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring.

TL;DR: Conventional serological assays, such as enzyme-linked immunoassay (ELISA) for specific IgM and IgG antibodies, should offer a high-throughput alternative, which allows for uniform tests for all suspected patients, and can facilitate more complete identification of infected cases and avoidance of unnecessary cross infection among unselected patients.
Journal ArticleDOI

Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.

TL;DR: The data suggest that a significant portion of patients are failing first-line regimens with a trend of AIDS progression, and it is therefore necessary to maximize the drug adherence and to make affordable second-line HAART regimens available immediately.
Journal ArticleDOI

The route of inoculation determines the tissue tropism of modified vaccinia tiantan expressing the spike glycoprotein of SARS‐CoV in mice

TL;DR: It was found that MVTT‐S was able to produce a transient infection in all cases within 48 hr post‐inoculation, yet the major site of viral replication in various tissues or organs was dependent on the route of viral administration.
Journal ArticleDOI

Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera

TL;DR: The results showed that the Omicron variant may evade antibodies induced by the ancestral strain and by the inactivated vaccine, with significant reduction in the binding capability of its RBD much greater than that of the Delta variant.